TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breast
- 1 June 1996
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 41 (2) , 103-109
- https://doi.org/10.1007/bf01807155
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Alterations of the TP53 Gene as a Potential Prognostic Marker in Breast CarcinomasDiagnostic Molecular Pathology, 1995
- TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domainsGenes, Chromosomes and Cancer, 1995
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- The tumore suppressor p53Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic GradeJapanese Journal of Cancer Research, 1993
- Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteriThe Journal of Pathology, 1993
- Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniquesHuman Mutation, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The p53 tumour suppressor geneNature, 1991
- Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitroInternational Journal of Cancer, 1990